ArticleDiscover oncology2025

Liraglutide inhibits the development of colorectal cancer by regulating TGF-β/Smad3 signaling pathway and affecting epithelial-mesenchymal transition.

Xinjian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.